December 2023

Marcel Louis-Jacques, ESPNDec 12, 2023, 02:11 AM ETCloseMarcel Louis-Jacques joined ESPN in 2019 as a beat reporter covering the Buffalo Bills, before switching to the Miami Dolphins in 2021. The former Carolina Panthers beat writer for the…

NLE Choppa recently got pulled into a verbal tussle between his child’s mother and Blueface. On Sunday (Dec. 10), Blueface and Marissa Da’Nae exchanged words on X (formerly…

Sopa Images | Lightrocket | Getty ImagesShares of Cigna jumped Monday following reports that the health-care giant has scrapped its plans to buy rival Humana due to disagreements on price, putting an early end to what would have been one of…

For a long time, we wondered if other stars hosted planets like the Sun does. Finally, in the 1990s, we got our answer. Now, another question lingers. Most of the planets in our Solar System have moons. Do exoplanets have exomoons? Moons…

2023 has been a tough funding year for European fintech startups, with raised capital dropping 70% drop in H1 compared to the same period in 2022. But against this backdrop, British payment startup SumUp has…

Rob Demovsky, ESPN Staff WriterDec 11, 2023, 06:00 AM ETCloseRob Demovsky is an NFL reporter at ESPN and covers the Green Bay Packers. He has covered the Packers since 1997 and joined ESPN in 2013. Demovsky is a two-time Wisconsin…

At age 19, Joe Tsogbe underwent his first hip replacement. In his 20s, he averaged about nine hospitalizations a year. By his 30s, that rose to more than a dozen. All the result of sickle cell disease, an inherited blood disorder where a…

Alana "Honey Boo Boo" ThompsonAnna's little sister, star of Toddlers & Tiaras and Here Comes Honey Boo Boo, who later appeared with her mom on Mama June: From Not to Hot, wrote on her Instagram, "This is one post I wish I didn’t have to…

Wei Wang1, Yunzhong Shen3,1, Qiujie Chen1 and Fengwei Wang2 Published 9 November 2023 • © 2023 The Author(s). Published by IOP Publishing LtdEnvironmental Research Letters, Volume 18, Number 12 Citation Wei Wang et al 2023 …

AbbVie on Wednesday said it will acquire neuroscience drugmaker Cerevel Therapeutics for roughly $8.7 billion. Under the terms of the deal, AbbVie will pay $45 per share for Cerevel. AbbVie said it expects to complete the acquisition in the…